Venous Thromboembolism
📧 Sign up to get email alerts when something new happens for Venous Thromboembolism.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2026-08-25EMA Authorised: Svariya (previously Rivaroxaban Koanaa) (rivaroxaban) — Koanaa Healthcare GmbH
EMA authorised Svariya (rivaroxaban) for prevention and treatment uses related to thromboembolic conditions; managed by Koanaa Healthcare Gm…
-
EMA approval · 2026-07-27EMA Authorised: Apixaban Accord (apixaban) — Accord Healthcare S.L.U.
Authorised status for Apixaban Accord (apixaban) by Accord Healthcare S.L.U. for venous thromboembolism, stroke, and arthroplasty indication…
-
EMA approval · 2026-07-16EMA Authorised: Inhixa (enoxaparin sodium) — Techdow Pharma Netherlands B.V.
The EMA has authorised Inhixa (enoxaparin sodium) for Venous Thromboembolism, with Techdow Pharma Netherlands B.V. as the marketing authoriz…
-
CLINICAL_TRIALS trial_result · 2026-06-24Clinical Trial Results: Comparison of Bleeding Risk Between Rivaroxaban and Apixaban for the Treatment of Acute Venous Thromboembolism [Phase 4]
Phase 4 trial comparing bleeding risk between rivaroxaban and apixaban for treatment of venous thromboembolism; results posted and study com…
-
CLINICAL_TRIALS trial_result · 2026-06-16Clinical Trial Update: VTE Prevention Following Total Hip and Knee Arthroplasty [Phase 3]
A Phase 3 clinical trial update on venous thromboembolism prevention after total hip and knee arthroplasty has been completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-06-02Clinical Trial Results: A Study in the United Sates That Looks at the Safety and Effectiveness of Pradaxa Pellets in Children Aged 3 Months to Less Than 12 Years Who Need Treatment of a Blood Clot or Who Have Had a Blood Clot and Are at Risk of Developing Another Blood Clot
Clinical trial evaluating safety and effectiveness of Pradaxa pellets in children aged 3 months to under 12 years with venous thromboembolis…
-
CLINICAL_TRIALS trial_result · 2026-04-27Clinical Trial Update: Collaborative Risk-stratified Investigation in Thrombosis-prone Inpatients With Critical Illness: Anticoagulation With LMWH in Teens for ThromboProphylaxis (CRITICAL-Teens-TP). [Phase 3]
A Phase 3 clinical trial evaluating low-molecular-weight heparin for thromboprophylaxis in teens at risk of venous thromboembolism, currentl…
-
CLINICAL_TRIALS trial_result · 2026-04-24Clinical Trial Update: Xarelto for Thromboprophylaxis After Total Hip and Total Knee Arthroplasty [NA]
Results from a clinical trial of rivaroxaban (Xarelto) for thromboprophylaxis after total hip and total knee arthroplasty have been posted.
-
CLINICAL_TRIALS trial_result · 2026-04-24Clinical Trial Update: Personalized Medicine Decision-Making in a Virtual Clinical Setting
A completed NHGRI-sponsored trial examines how personalized medicine decision-making can be implemented in a virtual clinical setting for co…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: THRomboprophylaxis in Individuals Undergoing Superficial endoVEnous Treatment (THRIVE) [Phase 4]
A Phase 4 trial named THRomboprophylaxis in Individuals Undergoing Superficial Endovenous Treatment (THRIVE) is currently recruiting, sponso…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: REGN7508 Versus Acetylsalicylic Acid (ASA) for Venous Thromboprophylaxis After Total Knee Arthroplasty in Adult Participants [Phase 3]
Phase 3 trial comparing REGN7508 to acetylsalicylic acid for venous thromboembolism prevention after total knee arthroplasty; the study is c…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Evaluation of the SCALED (SCaling AcceptabLE cDs)
Clinical trial update indicates the SCALED study is currently recruiting at the University of Minnesota. The study targets conditions includ…
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: Collection of Blood Samples for New Diagnostic Devices 2 [NA]
LumiraDx UK Limited is recruiting for a study to collect blood samples to evaluate new diagnostic devices across cardiovascular, renal, infl…
-
EMA approval · 2026-04-22EMA Authorised: Dabigatran Etexilate Accord (dabigatran etexilate mesilate) — Accord Healthcare S.L.U.
The EMA authorised the generic dabigatran etexilate mesilate product 'Dabigatran Etexilate Accord' by Accord Healthcare S.L.U. for preventio…
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: An Observational Study to Learn More About How Safe Rivaroxaban is And How Well it Works in Children With Congenital Heart Disease Who Had a Heart Surgery Called the Fontan Procedure
This is an observational study to evaluate the safety and effectiveness of rivaroxaban in children with congenital heart disease who have ha…
-
EMA approval · 2026-04-20EMA Authorised: Lixiana (edoxaban tosilate) — Daiichi Sankyo Europe GmbH
The EMA authorised Lixiana (edoxaban tosilate) from Daiichi Sankyo Europe GmbH for indications related to stroke and venous thromboembolism.
-
EMA approval · 2026-04-20EMA Authorised: Roteas (edoxaban tosilate) — Berlin-Chemie AG
The European Medicines Agency authorised Roteas, a product containing edoxaban, for indications related to stroke prevention and venous thro…
-
CLINICAL_TRIALS trial_result · 2026-04-17Clinical Trial Update: A Study Comparing Abelacimab to Dalteparin in the Treatment of Gastrointestinal/Genitourinary Cancer and Associated VTE [Phase 3]
A Phase 3 study comparing Abelacimab to dalteparin for cancer-associated venous thromboembolism in gastrointestinal/genitourinary cancer has…
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: Post-Market Celect Platinum Vena Cava Filter and Gunther Tulip Retrieval Set Study
A post-market clinical trial evaluating the Celect Platinum Vena Cava Filter and Gunther Tulip Retrieval Set is currently recruiting to asse…
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: A Study to Observe the Pattern of Use and Safety of Rivaroxaban in Children Under 2 Years Old With Venous Thromboembolism (VTE)
A planned observational study to assess how rivaroxaban is used and its safety in children under 2 with venous thromboembolism; recruitment …
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Apixaban in Thrombocytopenia [EARLY_Phase 1]
This is an early Phase 1 clinical trial update on apixaban in patients with thrombocytopenia, including Deep Vein Thrombosis and Pulmonary E…
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: An Observational Study in the United States to Learn How Venous Thromboembolism, Disseminated Intravascular Coagulation, and Sepsis Are Related
An observational U.S. study sponsored by Bayer aims to understand how sepsis, venous thromboembolism, and disseminated intravascular coagula…
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: The ReCAna for Lower ExtremIty Venous OBstructions and In-StEnt Restenosis Registry
A registry study sponsored by Intervene, Inc. to evaluate lower extremity venous obstructions and in-stent restenosis, currently not recruit…
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: A Clinical Study of SHR-2004 Injection in Preventing Venous Thromboembolism in Patients Undergoing Total Knee Arthroplasty [Phase 3]
Phase 3 clinical trial of SHR-2004 Injection for prevention of venous thromboembolism in total knee arthroplasty patients has completed. The…
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: A Trial to Learn How Well REGN9933 and REGN7508 Work for Preventing Blood Clots, and How Safe They Are, in Adults Who Have a Peripherally Inserted Central Catheter (PICC) [Phase 2]
A Phase 2 trial evaluating REGN9933 and REGN7508 for preventing venous thromboembolism in adults with a peripherally inserted central cathet…